Chiara Parravicini

1.8k total citations
40 papers, 1.4k citations indexed

About

Chiara Parravicini is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Oncology. According to data from OpenAlex, Chiara Parravicini has authored 40 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Molecular Biology, 14 papers in Cellular and Molecular Neuroscience and 9 papers in Oncology. Recurrent topics in Chiara Parravicini's work include Receptor Mechanisms and Signaling (11 papers), Neuropeptides and Animal Physiology (9 papers) and Chemical Synthesis and Analysis (4 papers). Chiara Parravicini is often cited by papers focused on Receptor Mechanisms and Signaling (11 papers), Neuropeptides and Animal Physiology (9 papers) and Chemical Synthesis and Analysis (4 papers). Chiara Parravicini collaborates with scholars based in Italy, Austria and Germany. Chiara Parravicini's co-authors include Ivano Eberini, Maria P. Abbracchio, Maria Letizia Trincavelli, Claudia Martini, Davide Lecca, Marta Fumagalli, Luca Palazzolo, Patrizia Rosa, Claudia Verderio and Simona Daniele and has published in prestigious journals such as Journal of Biological Chemistry, The EMBO Journal and PLoS ONE.

In The Last Decade

Chiara Parravicini

40 papers receiving 1.4k citations

Peers

Countries citing papers authored by Chiara Parravicini

Since Specialization

Citations

This map shows the geographic impact of Chiara Parravicini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chiara Parravicini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chiara Parravicini more than expected).

Fields of papers citing papers by Chiara Parravicini

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chiara Parravicini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chiara Parravicini. The network helps show where Chiara Parravicini may publish in the future.

Co-authorship network of co-authors of Chiara Parravicini

This figure shows the co-authorship network connecting the top 25 collaborators of Chiara Parravicini. A scholar is included among the top collaborators of Chiara Parravicini based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chiara Parravicini. Chiara Parravicini is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Rabphilin-3A as a novel target to reverse α-synuclein-induced synaptic loss in Parkinson’s disease 2022 ·Pharmacological Research ·Elena Ferrari, Diego Scheggia, Elisa Zianni, (unknown), (unknown), Luca Palazzolo, Chiara Parravicini, Andrea Pilotto, Alessandro Padovani, Elena Marcello, Ivano Eberini, Paolo Calabresi, Mónica Di Luca, Fabrizio Gardoni	18
2	IgG1 conformational behavior: elucidation of the N-glycosylation role via molecular dynamics 2021 ·Biophysical Journal ·(unknown), Chiara Parravicini, Carlo Pergola, Uliano Guerrini, Mariateresa Rossi, (unknown), Ivano Eberini	22
3	Development of the first in vivo GPR17 ligand through an iterative drug discovery pipeline: A novel disease-modifying strategy for multiple sclerosis 2020 ·PLoS ONE ·Chiara Parravicini, Davide Lecca, Davide Marangon, G. Coppolino, Simona Daniele, Elisabetta Bonfanti, Marta Fumagalli, Luca F. Raveglia, Claudia Martini, Elisabetta Gianazza, Maria Letizia Trincavelli, Maria P. Abbracchio, Ivano Eberini	19
4	Surface Plasmon Resonance as a Tool for Ligand Binding Investigation of Engineered GPR17 Receptor, a G Protein Coupled Receptor Involved in Myelination 2020 ·Frontiers in Chemistry ·Davide Capelli, Chiara Parravicini, G. Pochetti, Roberta Montanari, Caterina Temporini, Marco Rabuffetti, Maria Letizia Trincavelli, Simona Daniele, Marta Fumagalli, (unknown), Elisabetta Bonfanti, Maria P. Abbracchio, Ivano Eberini, Stefania Ceruti, Enrica Calleri, Stefano Capaldi	27
5	rHDL modeling and the anchoring mechanism of LCAT activation 2020 ·Journal of Lipid Research ·(unknown), Chiara Parravicini, Luca Palazzolo, Uliano Guerrini, Elisabetta Gianazza, Laura Calabresi, Ivano Eberini	9
6	Set-Up and Validation of a High Throughput Screening Method for Human Monoacylglycerol Lipase (MAGL) Based on a New Red Fluorescent Probe 2019 ·Molecules ·(unknown), Silvana Casati, Roberta Ottria, (unknown), Ivano Eberini, Luca Palazzolo, Chiara Parravicini, Pierangela Ciuffreda	11
7	Inhibition of SIRT1 deacetylase and p53 activation uncouples the anti-inflammatory and chemopreventive actions of NSAIDs 2019 ·British Journal of Cancer ·Giulia Dell’Omo, (unknown), (unknown), Chiara Parravicini, (unknown), Nicoletta Rizzi, Mariangela Garofalo, Andrea Pinto, Camilla Recordati, Eugenio Scanziani, Fabio Bassi, Giancarlo Pruneri, Paola Conti, Ivano Eberini, Adriana Maggi, Paolo Ciana	41
8	Gender proteomics II. Which proteins in sexual organs 2017 ·Journal of Proteomics ·Elisabetta Gianazza, Ingrid Miller, Uliano Guerrini, Luca Palazzolo, Chiara Parravicini, Ivano Eberini	3
9	Gender proteomics I. Which proteins in non-sexual organs 2017 ·Journal of Proteomics ·Elisabetta Gianazza, Ingrid Miller, Uliano Guerrini, Luca Palazzolo, Chiara Parravicini, Ivano Eberini	12
10	Potent inhibitors of human LAT1 (SLC7A5) transporter based on dithiazole and dithiazine compounds for development of anticancer drugs 2017 ·Biochemical Pharmacology ·(unknown), Mariafrancesca Scalise, Maria Koyioni, Panayiotis A. Koutentis, Marco Catto, Ivano Eberini, Chiara Parravicini, Luca Palazzolo, Leonardo Pisani, Michele Galluccio, Lara Console, Angelo Carotti, Cesare Indiveri	62
11	In silico prediction and characterization of protein post-translational modifications 2015 ·Journal of Proteomics ·Elisabetta Gianazza, Chiara Parravicini, Roberto Primi, Ingrid Miller, Ivano Eberini	10
12	A Computational Approach to Evaluate the Androgenic Affinity of Iprodione, Procymidone, Vinclozolin and Their Metabolites 2014 ·PLoS ONE ·C. Galli, Cristina Sensi, (unknown), Chiara Parravicini, Marina Marinovich, Ivano Eberini	41
13	Oxysterols act as promiscuous ligands of class-A GPCRs: In silico molecular modeling and in vitro validation 2014 ·Cellular Signalling ·Cristina Sensi, Simona Daniele, Chiara Parravicini, Elisa Zappelli, Vincenzo Russo, Maria Letizia Trincavelli, Claudia Martini, Maria P. Abbracchio, Ivano Eberini	30
14	Ventral tegmental area/substantia nigra and prefrontal cortex rodent organotypic brain slices as an integrated model to study the cellular changes induced by oxygen/glucose deprivation and reperfusion: Effect of neuroprotective agents 2014 ·Neurochemistry International ·(unknown), Chiara Parravicini, Davide Lecca, Elena Dossi, Claudia Heine, Mauro Cimino, (unknown), Péter Illés, Heike Franke, Maria P. Abbracchio	4
15	Changes of the GPR17 receptor, a new target for neurorepair, in neurons and glial cells in patients with traumatic brain injury 2013 ·Purinergic Signalling ·Heike Franke, Chiara Parravicini, Davide Lecca, Elisa R. Zanier, Claudia Heine, (unknown), Marta Fumagalli, Patrizia Rosa, Luca Longhi, Nino Stocchetti, Maria Grazia De Simoni, Marco Weber, Maria P. Abbracchio	59
16	In silico identification of new ligands for GPR17: a promising therapeutic target for neurodegenerative diseases 2011 ·Journal of Computer-Aided Molecular Design ·Ivano Eberini, Simona Daniele, Chiara Parravicini, Cristina Sensi, Maria Letizia Trincavelli, Claudia Martini, Maria P. Abbracchio	48
17	Frontal affinity chromatography-mass spectrometry useful for characterization of new ligands for GPR17 receptor 2010 ·Purinergic Signalling ·Stefania Ceruti, Enrica Calleri, G. Cristalli, Claudia Martini, Caterina Temporini, Chiara Parravicini, Rosaria Volpini, Simona Daniele, Gabriele Caccialanza, Davide Lecca, Catia Lambertucci, (unknown), Gabriella Marucci, (unknown), Graziella Ranghino, Piercarlo Fantucci, Maria P. Abbracchio, Gabriella Massolini	2
18	The orphan receptor GPR17 identified as a new dual uracil nucleotides/cysteinyl‐leukotrienes receptor 2006 ·The EMBO Journal ·Paolo Ciana, Marta Fumagalli, Maria Letizia Trincavelli, Claudia Verderio, Patrizia Rosa, Davide Lecca, Silvia Ferrario, Chiara Parravicini, Valérie Capra, Paolo Gelosa, Uliano Guerrini, Silvia Belcredito, Mauro Cimino, Luigi Sironi, Elena Tremoli, G. Enrico Rovati, Claudia Martini, Maria P. Abbracchio	354
19	Neuroimmunology in multiple sclerosis 1983 ·Neurological Sciences ·C. L. Cazzullo, Domenico Caputo, Chiara Parravicini	1
20	Counting Back from a Visually Presented Digit Increases Recall Asymmetries Between Hemispheres: A Brown-Peterson Experiment with Lateral Projection of Trigrams 1981 ·Cortex ·Chiara Parravicini, Hans Spinnler, Roberto Sterzi, Giuseppe Vallar	3

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact